OMEGA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jun 2025)
What this means for you
This application is over — abandoned 30 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98377106
- Mark type
- Stylized text
- Filed
- 26 Jan 2024
- Published for opposition
- 01 Oct 2024
- Abandoned
- 30 Jun 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
Owner
- Omega Therapeutics, Inc., Cambridge, MA, US
- Omega Therapeutics, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 30 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 22 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 22 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 21 Aug 2024 — ASSIGNED TO EXAMINER
- 25 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Jan 2024 — NEW APPLICATION ENTERED